Immune-related Encephalitis in Two Patients Treated With Immune Checkpoint Inhibitor

被引：9
|
作者：
Robert, Lucie [1 ,2 ]
Langner-Lemercier, Sophie [3 ]
Angibaud, Alexis [1 ]
Sale, Alexandre [1 ]
Thepault, Fanny [4 ]
Corre, Romain [1 ,5 ]
Lena, Herve [1 ,5 ]
Ricordel, Charles [1 ,5 ]
机构：
[1] CHU Rennes, Resp Med Dept, Rennes, France
[2] CLCC Eugene Marquis, Serv Oncol Med, Rennes, France
[3] CHU Rennes, Neurol Dept, Rennes, France
[4] CH St Malo, Resp Med Dept, St Malo, France
[5] CLCC Eugene Marquis, Chem Oncogenesis Stress & Signaling, INSERM, U1242, Rennes, France
来源：
CLINICAL LUNG CANCER | 2020年 / 21卷 / 05期
关键词：
Atezolizumab; Immune encephalitis; Immune-related adverse events; NSCLC; Nivolumab; NEUROLOGICAL TOXICITIES; IPILIMUMAB; MELANOMA;
D O I：
10.1016/j.cllc.2020.03.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E474 / E477
页数：4
相关论文
共 50 条
  • [31] Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment
    Muir, Christopher A.
    Clifton-Bligh, Roderick J.
    Long, Georgina, V
    Scolyer, Richard A.
    Lo, Serigne N.
    Carlino, Matteo S.
    Tsang, Venessa H. M.
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : E3704 - E3713
  • [32] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
    Zhou, Nanruoyi
    Velez, Maria A.
    Owen, Dwight
    Lisberg, Aaron E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
  • [33] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
    Liu, Jie
    Yu, Jinming
    Meng, Xue
    JAMA ONCOLOGY, 2020, 6 (11) : 1813 - +
  • [34] Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
    Iyer, Priyanka C.
    Cabanillas, Maria E.
    Waguespack, Steven G.
    Hu, Mimi I.
    Thosani, Sonali
    Lavis, Victor R.
    Busaidy, Naifa L.
    Subudhi, Sumit K.
    Diab, Adi
    Dadu, Ramona
    THYROID, 2018, 28 (10) : 1243 - 1251
  • [35] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [36] Immune-related adverse events and symptom burden in patients with melanoma receiving adjuvant immune checkpoint inhibitor
    Abdel-Wahab, Noha
    Kus, Teresa
    Bentebibel, Salah-Eddine
    McQuade, Jennifer Leigh
    Glitza, Isabella Claudia
    Amaria, Rodabe Navroze
    Patel, Sapna Pradyuman
    Wong, Michael K. K.
    Tawbi, Hussein A.
    Davies, Michael A.
    Peterson, Susan K.
    Shete, Sanjay
    Yee, Cassian
    Kavelaars, Annemieke
    Suarez-Almazor, Maria E.
    Diab, Adi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [38] Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
    Pan, Catherina X.
    Liu, Mofei
    Lau, Charles B.
    Lau, William C.
    Kim, Daniel Y.
    Saberi, Shahin A.
    Rowley, Rachael
    Kanwar, Ruhi
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : 826 - 829
  • [39] Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review
    Abdel-Rahman, Omar
    Oweira, Hani
    Petrausch, Ulf
    Helbling, Daniel
    Schmidt, Jan
    Mannhart, Meinrad
    Mehrabi, Arianeb
    Schoeb, Othmar
    Giryes, Anwar
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 387 - 394
  • [40] PHYSICIAN AWARENESS OF RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Araujo, F.
    Fonseca, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1777 - 1778
12345